Speakers

Philip Morton

Chief Technology Officer • Albumedix

Philip Morton has a strong technology background with over 25 years of experience in the biopharmaceutical industry, working across process and product development, and product application research. As the Chief Technology Officer of Albumedix, Dr Morton leads a team of specialists to refine recombinant albumin technologies and harness the multifaceted protein that is albumin. 

 

Also speaking

Image

Antonin de Fougerolles

Chief Executive Officer • Evox Therapeutics
4 May 2023
Image

Ben Weil

Director of Manufacturing  • INmune Bio
7 June 2023
Image

John Garcia

PhD, Head of New Manufacturing Technologies • UCL
5 May 2023

Event Info

Image

Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.
31 July 2023
Image

Partnering

Find out more about partnering at Advanced Therapies Europe.
27 July 2023